TANG CAPITAL MANAGEMENT LLC Q2 2019 Filing
Filed August 14, 2019
Portfolio Value
$740.0B
Holdings
10
Report Date
Q2 2019
Filing Type
13F-HR
All Holdings (10 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —ODONATE THERAPEUTICS INC | 14,075,269 | $516.4B | 69.79% | |
| 2 | HRTXHERON THERAPEUTICS INC | 5,744,096 | $106.8B | 14.43% | |
| 3 | —LA JOLLA PHARMACEUTICAL CO | 4,938,893 | $45.7B | 6.17% | |
| 4 | RCKTROCKET PHARMACEUTICALS INC | 2,965,485 | $44.5B | 6.01% | |
| 5 | CELGCELGENE CORP | 111,844 | $10.3B | 1.40% | |
| 6 | GTHXEURG1 THERAPEUTICS INC | 200,000 | $6.1B | 0.83% | |
| 7 | PBYIPUMA BIOTECHNOLOGY INC | 349,400 | $4.4B | 0.60% | |
| 8 | PRTAPROTHENA CORP PLC | 323,823 | $3.4B | 0.46% | |
| 9 | —CELLECTAR BIOSCIENCES INC | 680,000 | $1.5B | 0.20% | |
| 10 | OPHTEURIVERIC BIO INC | 600,000 | $780.0M | 0.11% |